| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO | Director | President &CEO
2 companies
Khattar Jack A. is a President, CEO at SUPN, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 41 sales.
Our model assigns Khattar Jack A. a middling insider score of 64/100, based on 34 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +15.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 25,446 | $40.03 | $1,018,728.07 | -3.1% | -8.3% | -30.4% | |
| Dec 21, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 15,360 | $38.11 | $585,386.88 | -1.9% | -3.1% | -24.5% | |
| Nov 25, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 13,394 | $35.16 | $470,873.55 | -1.7% | +9.6% | -21.0% | |
| Nov 22, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 600 | $35.00 | $21,001.08 | - | +11.1% | -21.5% | |
| Nov 21, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 531 | $35.01 | $18,592.22 | - | +12.1% | -21.4% | |
| Nov 15, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 1,115 | $35.00 | $39,028.01 | -0.1% | +16.0% | -15.9% | |
| Aug 16, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 14,690 | $34.01 | $499,650.97 | -1.9% | +1.5% | -8.9% | |
| Aug 15, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 17,302 | $34.03 | $588,752.46 | -2.2% | +1.5% | -6.3% | |
| Aug 10, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 28,437 | $31.22 | $887,803.14 | -3.7% | +9.8% | +0.6% | |
| Aug 9, 2022 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 39,431 | $31.15 | $1,228,275.65 | -5.2% | +11.9% | -1.6% |